Watch Demo
Critical Barriers
VedTechBio’s 3 Pillar Model
PROBLEM
SPEED
Early discovery alone typically takes 3-4 years before pre-clinical studies
COST
$15-20 million is often spent before pre-clinical entry, much of it lost to failed hypotheses
SUCCESS
~10% success rate from early discovery to pre-clinical entry
SOLUTION
RXAgentAi
An advanced Agentic AI which utilizes multiple specialized agents working in coordination to tackle complex tasks
Venture Studio
Venture Studio is a powerful engine that turns scientific ideas into drug candidates and creates successful biotech enterprises
Expert in-the-loop
Our team of experienced domain experts work in conjucture with RxAgentAi to deliver cutting edge drug discovery solutions
OUTCOME
SPEED
Pre-IND readiness achieved in 12-24 months versus 3-4 years traditionally
COST
IND-ready assets delivered at $1.5-2.0 million per program versus $15-20 million
SUCCESS
Proven delivery across multiple client and venture programs, driving translational confidence
Building the Next Generation of AI-Driven Therapeutics
3 IND-Ready Assets /Year
Venture studio production capacity
1 Venture Launched
RenaissThera
< 2 Years
Concept to venture-backed obesity asset
3 Active Programs
Advancing toward preclinical translation
3 New Programs /Year
Enabled with additional funding
Agentic AI Meets Drug Research -
The RxAgentAi Approach to Empowering Life Sciences
Our Partners
